MD Anderson Cancer Center at Cooper - Moorestown

Clinical research site in Moorestown, New Jersey

As of July 2026, 1 paid clinical trial is recruiting at MD Anderson Cancer Center at Cooper - Moorestown in Moorestown, New Jersey. Active studies at this site cover conditions such as Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 and Anatomic Stage IIIB Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at MD Anderson Cancer Center at Cooper - Moorestown (1)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

for Anatomic Stage II Breast Cancer AJCC v8

776 locations incl. Fairhope

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT05812807·Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

More research sites in Moorestown

Virtua Samson Cancer Center (9 trials)
Cooper Univ Hlthcr Moorestown Cmps (1 trial)
GSK Investigational Site (1 trial)
Virtua Crohns and Colitis Center (1 trial)
Virtua Health & Wellness Center - Moorestown (1 trial)
Virtua Reconstructive Orthopedics (1 trial)

Explore more

Paid clinical trials in Moorestown, NJ · New Jersey clinical trials